US FDA approves XVIVO lung preservation device | Organ Donation & Transplant Matters Resources |

The U.S. Food and Drug Administration has approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated lungs that do not initially meet the standard criteria for transplantation.


The XVIVO XPS lung perfusion system is one of several devices currently being trialed around the world. It is now hoped that with the judicious use of this type of technology that more donor lungs will be deemed suitable for transplantation. Once this technology becomes more widely available it is anticipated that this should lead to an increase in the numbers of lung transplants over the next 2-5 years.